Hyperlipoproteinemia in adults with renal disease.
Hyperlipoproteinemia is common in patients with renal disease, but increased lipids are only one of several risk factors frequently identified for coronary artery disease. Before treatment options are instituted, renal disease status, current medications, and possible interactions between drugs must be considered. Hypertriglyceridemia is common in patients with renal failure; therapeutic options are influenced by the levels of serum triglycerides and high-density lipoprotein cholesterol. If nonsteroidal drugs improve renal function and decrease proteinuria in patients with renal disease, hyperlipidemia frequently abates. Interactions between drugs are important considerations when lipid-lowering drug treatment is prescribed in recipients of renal transplants.
Anderson
C F
CF
Division of Nephrology, Mayo Clinic, Rochester, MN 55905.
D000328:Adult; D006801:Humans; D006951:Hyperlipoproteinemias / Q000209:etiology* / Q000628:therapy; D007674:Kidney Diseases / Q000150:complications*; D007676:Kidney Failure, Chronic / Q000150:complications; D016030:Kidney Transplantation; D008055:Lipids / Q000097:blood; D009404:Nephrotic Syndrome / Q000150:complications; D014280:Triglycerides / Q000097:blood
D008055:Lipids; D014280:Triglycerides